Europe Inflammatory Bowel Disease Treatment Market By Type (Crohn's Disease and Ulcerative Colitis), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), By Route of Administration (Injectable and Oral), By Drug Class (TNF inhibitors, Anti-integrin, IL inhibitors, Corticosteroids, JAK inhibitors, Aminosalicylates and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

The Europe Inflammatory Bowel Disease Treatment Market would witness market growth of 7.3% CAGR during the forecast period (2021-2027).

The main types of inflammatory disease are ulcerative colitis and Crohn’s disease. Patients suffering from Crohn’s disease may experience swelling and pain in the digestive tract. Also, patients can witness its effect on any part of the body from the mouth to the anus. It has a greater impact on the upper part of the large intestine and whole small intestine, majorly. In ulcerative colitis, patients witness swelling and sores (ulcers) in the large intestine (colon and rectum). Moreover, it causes intestinal inflammation that can be identified using a microscope.

The stressful & sedentary lifestyle and growing consumption of unhealthy drinks & food, leads to different digestive disorders and hence, boosting the demand for the market. Additionally, government and private companies are heavily investing in the healthcare sector which is estimated to escalate the growth of the market. Moreover, increasing research and development activities related to inflammatory bowel disease drugs will create new growth avenues for the inflammatory bowel disease treatment market in the forthcoming years. On the other hand, harmful effects like nausea, cramps, loss of appetite, and mild stomach pain, strict government regulations coupled with the efficacy and safety of the drug, and higher cost of drugs are the factors that would slow down the growth of the market in the coming years.

The inflammatory bowel disease treatment market is strongly growing in Europe. Europe comprises various well-established nations such as Spain, Norway, Germany, Italy, the UK, and France that are contributing to the growth of the inflammatory bowel disease treatment market. The increasing number of individuals engaged in smoking, evolving lifestyle, and rising prevalence of inflammatory bowel disease treatment are the factors supporting the growth of the market in this region.

Besides, the European Federation of Crohn's & Ulcerative Colitis Associations is the organization that continuously monitors inflammatory bowel disease patients in the region and is highly involved in the development of alternatives for inflammatory bowel disease treatment. Moreover, unhealthy eating and smoking practice, especially among youngsters has led to an increase in the prevalence of inflammatory bowel disease. Thus, these factors are anticipated to boost the demand and growth of the regional inflammatory bowel disease treatment market in the forthcoming period.

The Germany market dominated the Europe Aminosalicylates Inflammatory Bowel Disease Treatment Market by Country 2020, thereby, achieving a market value of $169.8 million by 2027. The UK market is exhibiting a CAGR of 8.8% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 11.2% during (2021 - 2027).

Based on Type, the market is segmented into Crohn's Disease and Ulcerative Colitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Route of Administration, the market is segmented into Injectable and Oral. BBased on Drug Class, the market is segmented into TNF inhibitors, Anti-integrin, IL inhibitors, Corticosteroids, JAK inhibitors, Aminosalicylates and Others. ased on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Inflammatory Bowel Disease Treatment Market Size will Hit $29.2 Billion by 2027, at a CAGR of 8.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie), Johnson & Johnson, Merck Group, Amgen, Inc., Eli Lilly and Company, Biogen, Inc., Pfizer, Inc., Novartis AG, Takeda Pharmaceutical Company Limited, and UCB S.A.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Crohn's Disease and
• Ulcerative Colitis

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Route of Administration

• Injectable
• Oral

By Drug Class

• TNF inhibitors
• Anti-integrin
• IL inhibitors
• Corticosteroids
• JAK inhibitors
• Aminosalicylates
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Allergan PLC (AbbVie)
• Johnson & Johnson
• Merck Group
• Amgen, Inc.
• Eli Lilly and Company
• Biogen, Inc.
• Pfizer, Inc.
• Novartis AG
• Takeda Pharmaceutical Company Limited
• UCB S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Inflammatory Bowel Disease Treatment Market, by Type
1.4.2 Europe Inflammatory Bowel Disease Treatment Market, by Distribution Channel
1.4.3 Europe Inflammatory Bowel Disease Treatment Market, by Route of Administration
1.4.4 Europe Inflammatory Bowel Disease Treatment Market, by Drug Class
1.4.5 Europe Inflammatory Bowel Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players

Chapter 4. Europe Inflammatory Bowel Disease Treatment Market by Type
4.1 Europe Crohn's Disease Market by Country
4.2 Europe Ulcerative Colitis Market by Country

Chapter 5. Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country

Chapter 6. Europe Inflammatory Bowel Disease Treatment Market by Route of Administration
6.1 Europe Injectable Market by Country
6.2 Europe Oral Market by Country

Chapter 7. Europe Inflammatory Bowel Disease Treatment Market by Drug Class
7.1 Europe TNF inhibitors Market by Country
7.2 Europe Anti-integrin Market by Country
7.3 Europe IL inhibitors Market by Country
7.4 Europe Corticosteroids Market by Country
7.5 Europe JAK inhibitors Market by Country
7.6 Europe Aminosalicylates Market by Country
7.7 Europe Others Market by Country

Chapter 8. Europe Inflammatory Bowel Disease Treatment Market by Country
8.1 Germany Inflammatory Bowel Disease Treatment Market
8.1.1 Germany Inflammatory Bowel Disease Treatment Market by Type
8.1.2 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.1.3 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration
8.1.4 Germany Inflammatory Bowel Disease Treatment Market by Drug Class
8.2 UK Inflammatory Bowel Disease Treatment Market
8.2.1 UK Inflammatory Bowel Disease Treatment Market by Type
8.2.2 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.2.3 UK Inflammatory Bowel Disease Treatment Market by Route of Administration
8.2.4 UK Inflammatory Bowel Disease Treatment Market by Drug Class
8.3 France Inflammatory Bowel Disease Treatment Market
8.3.1 France Inflammatory Bowel Disease Treatment Market by Type
8.3.2 France Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.3.3 France Inflammatory Bowel Disease Treatment Market by Route of Administration
8.3.4 France Inflammatory Bowel Disease Treatment Market by Drug Class
8.4 Russia Inflammatory Bowel Disease Treatment Market
8.4.1 Russia Inflammatory Bowel Disease Treatment Market by Type
8.4.2 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.4.3 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration
8.4.4 Russia Inflammatory Bowel Disease Treatment Market by Drug Class
8.5 Spain Inflammatory Bowel Disease Treatment Market
8.5.1 Spain Inflammatory Bowel Disease Treatment Market by Type
8.5.2 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.5.3 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration
8.5.4 Spain Inflammatory Bowel Disease Treatment Market by Drug Class
8.6 Italy Inflammatory Bowel Disease Treatment Market
8.6.1 Italy Inflammatory Bowel Disease Treatment Market by Type
8.6.2 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.6.3 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration
8.6.4 Italy Inflammatory Bowel Disease Treatment Market by Drug Class
8.7 Rest of Europe Inflammatory Bowel Disease Treatment Market
8.7.1 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type
8.7.2 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel
8.7.3 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration
8.7.4 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class

Chapter 9. Company Profiles
9.1 Allergan PLC (AbbVie)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Approvals and Trials:
9.2 Johnson & Johnson
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental &Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Approvals and Trials:
9.3 Merck Group
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisitions and Mergers:
9.3.5.3 Product Launches and Product Expansions:
9.4 Amgen, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisitions and Mergers:
9.4.5.3 Geographical Expansions:
9.4.5.4 Approvals and Trials:
9.5 Eli Lilly and Company
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.6 Biogen, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Approvals and Trials:
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisitions and Mergers:
9.7.5.2 Approvals and Trials:
9.8 Novartis AG
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisitions and Mergers:
9.8.5.3 Approvals and Trials:
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisitions and Mergers:
9.9.5.3 Product Launches and Product Expansions:
9.9.5.4 Approvals and Trials:
9.10. UCB S.A.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Approvals and Trials:

TABLE 1 Europe Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 2 Europe Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Inflammatory Bowel Disease Treatment Market
TABLE 4 Product Launches And Product Expansions– Inflammatory Bowel Disease Treatment Market
TABLE 5 Acquisition and Mergers– Inflammatory Bowel Disease Treatment Market
TABLE 6 Geographical Expansions– Inflammatory Bowel Disease Treatment Market
TABLE 7 Approvals and TRials– Inflammatory Bowel Disease Treatment Market
TABLE 8 Europe Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 9 Europe Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 10 Europe Crohn's Disease Market by Country, 2017 - 2020, USD Million
TABLE 11 Europe Crohn's Disease Market by Country, 2021 - 2027, USD Million
TABLE 12 Europe Ulcerative Colitis Market by Country, 2017 - 2020, USD Million
TABLE 13 Europe Ulcerative Colitis Market by Country, 2021 - 2027, USD Million
TABLE 14 Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 15 Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 16 Europe Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 17 Europe Hospital Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 18 Europe Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 19 Europe Retail Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 20 Europe Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 21 Europe Online Pharmacy Market by Country, 2021 - 2027, USD Million
TABLE 22 Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 23 Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 24 Europe Injectable Market by Country, 2017 - 2020, USD Million
TABLE 25 Europe Injectable Market by Country, 2021 - 2027, USD Million
TABLE 26 Europe Oral Market by Country, 2017 - 2020, USD Million
TABLE 27 Europe Oral Market by Country, 2021 - 2027, USD Million
TABLE 28 Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 29 Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 30 Europe TNF inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 31 Europe TNF inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 32 Europe Anti-integrin Market by Country, 2017 - 2020, USD Million
TABLE 33 Europe Anti-integrin Market by Country, 2021 - 2027, USD Million
TABLE 34 Europe IL inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 35 Europe IL inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 36 Europe Corticosteroids Market by Country, 2017 - 2020, USD Million
TABLE 37 Europe Corticosteroids Market by Country, 2021 - 2027, USD Million
TABLE 38 Europe JAK inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 39 Europe JAK inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 40 Europe Aminosalicylates Market by Country, 2017 - 2020, USD Million
TABLE 41 Europe Aminosalicylates Market by Country, 2021 - 2027, USD Million
TABLE 42 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 43 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 44 Europe Inflammatory Bowel Disease Treatment Market by Country, 2017 - 2020, USD Million
TABLE 45 Europe Inflammatory Bowel Disease Treatment Market by Country, 2021 - 2027, USD Million
TABLE 46 Germany Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 47 Germany Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 48 Germany Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 49 Germany Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 50 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 51 Germany Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 52 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 53 Germany Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 54 Germany Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 55 Germany Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 56 UK Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 57 UK Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 58 UK Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 59 UK Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 60 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 61 UK Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 62 UK Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 63 UK Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 64 UK Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 65 UK Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 66 France Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 67 France Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 68 France Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 69 France Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 70 France Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 71 France Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 72 France Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 73 France Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 74 France Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 75 France Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 76 Russia Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 77 Russia Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 78 Russia Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 79 Russia Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 80 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 81 Russia Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 82 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 83 Russia Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 84 Russia Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 85 Russia Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 86 Spain Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 87 Spain Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 88 Spain Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 89 Spain Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 90 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 91 Spain Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 92 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 93 Spain Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 94 Spain Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 95 Spain Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 96 Italy Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 97 Italy Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 98 Italy Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 99 Italy Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 100 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 101 Italy Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 102 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 103 Italy Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 104 Italy Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 105 Italy Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 106 Rest of Europe Inflammatory Bowel Disease Treatment Market, 2017 - 2020, USD Million
TABLE 107 Rest of Europe Inflammatory Bowel Disease Treatment Market, 2021 - 2027, USD Million
TABLE 108 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type, 2017 - 2020, USD Million
TABLE 109 Rest of Europe Inflammatory Bowel Disease Treatment Market by Type, 2021 - 2027, USD Million
TABLE 110 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 111 Rest of Europe Inflammatory Bowel Disease Treatment Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 112 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2017 - 2020, USD Million
TABLE 113 Rest of Europe Inflammatory Bowel Disease Treatment Market by Route of Administration, 2021 - 2027, USD Million
TABLE 114 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2017 - 2020, USD Million
TABLE 115 Rest of Europe Inflammatory Bowel Disease Treatment Market by Drug Class, 2021 - 2027, USD Million
TABLE 116 Key Information – Allergan PLC
TABLE 117 Key information –Johnson & Johnson
TABLE 118 key Information – Merck Group
TABLE 119 Key Information – Amgen, Inc.
TABLE 120 Key Information – Eli Lilly and Company
TABLE 121 Key Information – Biogen, Inc.
TABLE 122 Key Information – Pfizer, Inc.
TABLE 123 Key Information – Novartis AG
TABLE 124 Key Information – Takeda Pharmaceutical Company Limited
TABLE 125 Key Information – UCB S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Approvals and Trials : 2017, Aug – 2021, Sep) Leading Players
FIG 5 Recent strategies and developments: Merck Group
FIG 6 Recent strategies and developments: Amgen, Inc.
FIG 7 Recent strategies and developments: Biogen, Inc.
FIG 8 Recent strategies and developments: Pfizer, Inc.
FIG 9 Recent strategies and developments: Novartis AG
FIG 10 Recent strategies and developments: Takeda Pharmaceutical Company Limited